10:04 AM EST - Canopy Growth Corporation : Today announced its financial results for the fourth quarter and fiscal year ended March 31, 2024. Canada cannabis net revenue in Q4 FY2024 increased 4% as compared to Q4 FY2023 led by a 16% increase in the Canada medical cannabis business. Operating loss from continuing operations of $229 MM in FY2024. Adjusted EBITDA loss was $59 MM in FY2024, representing an improvement of 72% year-over-year,
Canopy Growth Corporation
shares T.WEED are trading $1.48 at $13.07.
